Infasurf (Calfactant) Drug Center: Guide to Drug Information for Professionals, Patients and Caregivers at RxList

Pill Identifier Search

May 27, 2012

« Previous
1
2
3
4
5
6
7
8
9
10
Next »

Infasurf

Adult Skin Problems Slideshow Pictures

How Smoking Affects Your Looks Slideshow Pictures

Weight Gain Shockers Slideshow

font size

Infasurf Drug Center

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Infasurf Prescribing Information: Indications & Dosage

Infasurf (calfactant) is indicated for the prevention of Respiratory Distress Syndrome (RDS) in premature infants at high risk for RDS and for the treatment (“rescue”) of premature infants who develop RDS. Infasurf (calfactant) decreases the incidence of RDS, mortality due to RDS, and air leaks associated with RDS.

Prophylaxis

Prophylaxis therapy at birth with Infasurf (calfactant) is indicated for premature infants < 29 weeks of gestational age at significant risk for RDS. Infasurf (calfactant) prophylaxis should be administered as soon as possib...

Read the complete drug monograph for Infasurf »

What is Infasurf Prescribing Information?

Drug Description - Indications & Dosage - Side Effects & Drug Interactions - Warnings & Precautions - Contraindications - Medication Guide and More

What is Patient information?

Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.

Infasurf Patient Information: Side Effects

Calfactant causes few side effects. There is a possibility that the baby will have breathing difficulties during the calfactant treatment, and these problems may require further treatment by health care professionals. Your baby will remain under constant supervision during treatment with calfactant.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.